ARTICLE | Finance
Asian leverage
Aslan taps Asian investors to move 3 compounds into Phase II by YE14
October 28, 2013 7:00 AM UTC
Aslan Pharmaceuticals Pte. Ltd. tapped into VCs with operational expertise in Asia for its latest round and plans to use the cash to build out its portfolio of in-licensed products.
Aslan raised $22 million this month in a series B led by new investor Cenova Ventures. New investors Morningside Group and XinChen Ventures joined existing investors BioVeda Capital and Sagamore Bioventures...